{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:42:39Z","timestamp":1792464159361,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["BMS-986202"],"award-info":[{"award-number":["BMS-986202"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX001733"],"award-info":[{"award-number":["I01BX001733"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014159","name":"George and Frances Ball Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014159","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UC4DK104166"],"award-info":[{"award-number":["UC4DK104166"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK127786"],"award-info":[{"award-number":["U01DK127786"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK127308"],"award-info":[{"award-number":["DK127308"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31DK134168"],"award-info":[{"award-number":["F31DK134168"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002529"],"award-info":[{"award-number":["UL1TR002529"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR M4C2-1.3"],"award-info":[{"award-number":["PNRR M4C2-1.3"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE_00000019"],"award-info":[{"award-number":["PE_00000019"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000989","name":"Ball Brothers Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"School of Medicine, Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["2-SRA-2018-493-A-B"],"award-info":[{"award-number":["2-SRA-2018-493-A-B"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["3-PDF-20016-199-A-N"],"award-info":[{"award-number":["3-PDF-20016-199-A-N"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ebiom.2025.105734","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:34:03Z","timestamp":1746560043000},"page":"105734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-0631","authenticated-orcid":false,"given":"Farooq","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Ballew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Castela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namratha Shivani","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia F.","family":"Thomaidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Demine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrick","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Coomans de Brach\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ines","family":"Alvelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia Martin","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorella","family":"Marselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Felton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Kaddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Zaldumbide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donalyn","family":"Scheuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decio L.","family":"Eizirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-8663","authenticated-orcid":false,"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.105734_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00535","article-title":"Type 1 diabetes mellitus-associated genetic variants contribute to overlapping immune regulatory networks","volume":"9","author":"Nyaga","year":"2018","journal-title":"Front Genet"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105734_bib4","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1007\/s11033-010-0601-5","article-title":"Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases","volume":"38","author":"Tao","year":"2011","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng.493","article-title":"The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes","volume":"42","author":"Wallace","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105734_bib6","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2020-0425","article-title":"Association of TYK2 polymorphisms with autoimmune diseases: a comprehensive and updated systematic review with meta-analysis","volume":"44","author":"Pellenz","year":"2021","journal-title":"Genet Mol Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105734_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4093\/dmj.2020.0194","article-title":"The rs2304256 polymorphism in TYK2 gene is associated with protection for type 1 diabetes mellitus","volume":"45","author":"Pellenz","year":"2021","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4049\/jimmunol.1003244","article-title":"Involvement of tyrosine kinase-2 in both the IL-12\/Th1 and IL-23\/Th17 Axes in vivo","volume":"187","author":"Ishizaki","year":"2011","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.ebiom.2025.105734_bib9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/imt-2021-0096","article-title":"TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases","volume":"13","author":"Gonciarz","year":"2021","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105734_bib10","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/db13-1777","article-title":"A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes","volume":"63","author":"Ferreira","year":"2014","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105734_bib11","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/db13-1775","article-title":"Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility","volume":"63","author":"Kallionp\u00e4\u00e4","year":"2014","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105734_bib12","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.2337\/db16-0616","article-title":"Expression of interferon-stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes","volume":"65","author":"Lundberg","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2025.105734_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.606332","article-title":"Innate immunity mediated inflammation and beta cell function: neighbors or enemies?","volume":"11","author":"Citro","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/ijms22041765","article-title":"Crosstalk between macrophages and pancreatic \u03b2-cells in islet development, homeostasis and disease","volume":"22","author":"Cosentino","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105734_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105734_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125067","article-title":"Macrophage IFN-I signaling promotes autoreactive T cell infiltration into islets in type 1 diabetes model","volume":"4","author":"Marro","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2025.105734_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01289","article-title":"IRE1\u03b1 implications in endoplasmic reticulum stress-mediated development and pathogenesis of autoimmune diseases","volume":"9","author":"Junjappa","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-\u03b1 mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2025.105734_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.624590","article-title":"The role of \u03b2 cell stress and neo-epitopes in the immunopathology of type 1 diabetes","volume":"11","author":"Piganelli","year":"2021","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105734_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd7600","article-title":"Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis","volume":"7","author":"Szymczak","year":"2021","journal-title":"Sci Adv"},{"issue":"37","key":"10.1016\/j.ebiom.2025.105734_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn5732","article-title":"Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic \u03b2 cells","volume":"8","author":"Szymczak","year":"2022","journal-title":"Sci Adv"},{"issue":"8818","key":"10.1016\/j.ebiom.2025.105734_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","article-title":"Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis","volume":"340","author":"Fabris","year":"1992","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1478-3231.2007.01610.x","article-title":"High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection","volume":"28","author":"Schreuder","year":"2008","journal-title":"Liver Int"},{"issue":"34","key":"10.1016\/j.ebiom.2025.105734_bib24","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1073\/pnas.0806439105","article-title":"Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2011.04.010","article-title":"The role of interferon alpha in initiation of type I diabetes in the NOD mouse","volume":"140","author":"Li","year":"2011","journal-title":"Clin Immunol"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105734_bib26","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1073\/pnas.1700878114","article-title":"Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-\u03b1 signaling","volume":"114","author":"Marro","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/db16-0462","article-title":"A critical role for the type I interferon receptor in virus-induced autoimmune diabetes in rats","volume":"66","author":"Qaisar","year":"2017","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105734_bib28","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/db16-1250","article-title":"Repurposed JAK1\/JAK2 inhibitor reverses established autoimmune insulitis in NOD mice","volume":"66","author":"Trivedi","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2025.105734_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-017-4536-4","article-title":"IFN-\u03b1 induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells","author":"Coomans de Brach\u00e8ne","year":"2018","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13063-022-06356-z","article-title":"Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)\u2014study protocol for a phase 2, randomized, placebo controlled trial","volume":"23","author":"Waibel","year":"2022","journal-title":"Trials"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105734_bib31","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.3390\/ijms21197390","article-title":"Clinical aspects of Janus kinase (JAK) inhibitors in the cardiovascular system in patients with rheumatoid arthritis","volume":"21","author":"Kotyla","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105734_bib32","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1007\/s10067-021-05911-4","article-title":"Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review","volume":"40","author":"Mori","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105734_bib33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1806382","article-title":"Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis","volume":"379","author":"Papp","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib34","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1038\/s41467-022-34069-z","article-title":"The type 1 diabetes gene TYK2 regulates \u03b2-cell development and its responses to interferon-\u03b1","volume":"13","author":"Chandra","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105734_bib35","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.2337\/db15-0362","article-title":"TYK2, a candidate gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic \u03b2-cells","volume":"64","author":"Marroqui","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2025.105734_bib36","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41467-024-45573-9","article-title":"TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes","volume":"15","author":"Mine","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/acs.jmedchem.0c01698","article-title":"Discovery of BMS-986202: a clinical Tyk2 inhibitor that binds to Tyk2 JH2","volume":"64","author":"Liu","year":"2021","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.ebiom.2025.105734_bib38","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/acs.jmedchem.9b00444","article-title":"Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165","volume":"62","author":"Wrobleski","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.ebiom.2025.105734_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2019.12.005","article-title":"Comprehensive proteomics analysis of stressed human islets identifies GDF15 as a target for type 1 diabetes intervention","volume":"31","author":"Nakayasu","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib40","first-page":"1","article-title":"Breeding of a non-obese, diabetic strain of mice","volume":"29","author":"Makino","year":"1980","journal-title":"Jikken Dobutsu"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105734_bib41","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1172\/JCI58447","article-title":"A genetically engineered human pancreatic \u03b2 cell line exhibiting glucose-inducible insulin secretion","volume":"121","author":"Ravassard","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2025.105734_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib43","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1038\/s41467-020-16327-0","article-title":"An integrated multi-omics approach identifies the landscape of interferon-\u03b1-mediated responses of human pancreatic beta cells","volume":"11","author":"Colli","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00125-024-06106-7","article-title":"Interferons are key cytokines acting on pancreatic islets in type 1 diabetes","volume":"67","author":"Coomans de Brach\u00e8ne","year":"2024","journal-title":"Diabetologia"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105734_bib45","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1093\/nar\/gky839","article-title":"Pancreatic \u03b2-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes","volume":"46","author":"Cosentino","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"Pt 14","key":"10.1016\/j.ebiom.2025.105734_bib46","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1242\/jcs.026062","article-title":"Initiation and execution of lipotoxic ER stress in pancreatic beta-cells","volume":"121","author":"Cunha","year":"2008","journal-title":"J Cell Sci"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105734_bib47","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI118950","article-title":"Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program","volume":"98","author":"Hoorens","year":"1996","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105734_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031062","article-title":"The transcription factor C\/EBP delta has anti-apoptotic and anti-inflammatory roles in pancreatic beta cells","volume":"7","author":"Moore","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105734_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymthe.2003.11.021","article-title":"Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes","volume":"9","author":"Carlotti","year":"2004","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00125-015-3779-1","article-title":"Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy","volume":"59","author":"van der Torren","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2025.105734_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101772","article-title":"EndoC-\u03b2H5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion","volume":"76","author":"Blanchi","year":"2023","journal-title":"Mol Metab"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105734_bib52","first-page":"3390","article-title":"CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope","volume":"118","author":"Skowera","year":"2008","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm.4289","article-title":"Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes","volume":"23","author":"Kracht","year":"2017","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib54","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2337\/db19-0984","article-title":"\u03b2-Cell stress shapes CTL immune recognition of preproinsulin signal peptide by posttranscriptional regulation of endoplasmic reticulum aminopeptidase 1","volume":"69","author":"Thomaidou","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2025.105734_bib55","doi-asserted-by":"crossref","DOI":"10.2337\/db20-1122","article-title":"Long-RNA sequencing and ribosome profiling of inflamed beta-cells reveal an extensive translatome landscape","author":"Thomaidou","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2025.105734_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104379","article-title":"A discovery-based proteomics approach identifies protein disulphide isomerase (PDIA1) as a biomarker of \u03b2 cell stress in type 1 diabetes","volume":"87","author":"Syed","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105734_bib57","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","article-title":"Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19","volume":"32","author":"Kusmartseva","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.105734_bib58","article-title":"The impact of pro-inflammatory cytokines on alternative splicing patterns in human islets","author":"Wu","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2025.105734_bib59","article-title":"Title: \u03b2 cell microRNAs function as molecular hubs of type 1 diabetes pathogenesis and as biomarkers of diabetes risk","author":"Syed","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ebiom.2025.105734_bib60","article-title":"Segment anything","author":"Kirillov","year":"2023","journal-title":"arXiv"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1109\/TPAMI.1987.4767946","article-title":"Fast convolution with laplacian-of-Gaussian masks","volume":"9","author":"Chen","year":"1987","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nmeth.2406","article-title":"FISH-quant: automatic counting of transcripts in 3D FISH images","volume":"10","author":"Mueller","year":"2013","journal-title":"Nat Methods"},{"issue":"396","key":"10.1016\/j.ebiom.2025.105734_bib63","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/01621459.1986.10478363","article-title":"Performance of some resistant rules for outlier labeling","volume":"81","author":"Hoaglin","year":"1986","journal-title":"J Am Stat Assoc"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105734_bib64","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41385-022-00572-1","article-title":"Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism","volume":"15","author":"Cavounidis","year":"2022","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-022-28020-5","article-title":"Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data","volume":"13","author":"Danaher","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib68","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1158\/2767-9764.CRC-22-0396","article-title":"Ultra high-plex spatial proteogenomic investigation of giant cell glioblastoma multiforme immune infiltrates reveals distinct protein and RNA expression profiles","volume":"3","author":"Bonnett","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib69","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/dneu.22419","article-title":"Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome","volume":"77","author":"Achuta","year":"2017","journal-title":"Dev Neurobiol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105734_bib70","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/dom.14104","article-title":"Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes","volume":"22","author":"Coomans de Brach\u00e8ne","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ebiom.2025.105734_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13287-019-1523-3","article-title":"Pro-inflammatory cytokines induce cell death, inflammatory responses, and endoplasmic reticulum stress in human iPSC-derived beta cells","volume":"11","author":"Demine","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"41","key":"10.1016\/j.ebiom.2025.105734_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107208118","article-title":"Human islet T cells are highly reactive to preproinsulin in type 1 diabetes","volume":"118","author":"Anderson","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib73","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/db17-0021","article-title":"Molecular pathways for immune recognition of preproinsulin signal peptide in type 1 diabetes","volume":"67","author":"Kronenberg-Versteeg","year":"2018","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00125-016-4125-y","article-title":"Immunogenicity of human embryonic stem cell-derived beta cells","volume":"60","author":"van der Torren","year":"2017","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105734_bib75","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00125-023-05991-8","article-title":"IFN\u0263 but not IFN\u03b1 increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity","volume":"66","author":"Thomaidou","year":"2023","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105734_bib76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2307\/2530564","article-title":"Estimation of the proportional hazard in two-treatment-group clinical trials","volume":"37","author":"Bernstein","year":"1981","journal-title":"Biometrics"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105734_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167166","article-title":"Single molecule RNA localization and translation in the mammalian oocyte and embryo","volume":"433","author":"Jansova","year":"2021","journal-title":"J Mol Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cell.2009.01.044","article-title":"mRNA localization: gene expression in the spatial dimension","volume":"136","author":"Martin","year":"2009","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105734_bib79","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/j.molcel.2024.08.002","article-title":"Spatial omics advances for in situ RNA biology","volume":"84","author":"Ren","year":"2024","journal-title":"Mol Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5483\/BMBRep.2010.43.5.355","article-title":"SAMD4B, a novel SAM-containing protein, inhibits AP-1-, p53- and p21-mediated transcriptional activity","volume":"43","author":"Luo","year":"2010","journal-title":"BMB Rep"},{"key":"10.1016\/j.ebiom.2025.105734_bib81","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24139","article-title":"Poly(A) tail length regulates PABPC1 expression to tune translation in the heart","volume":"6","author":"Chorghade","year":"2017","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib82","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032813","article-title":"Stress granules and processing bodies in translational control","volume":"11","author":"Ivanov","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ebiom.2025.105734_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8167496","article-title":"The expression, prognostic value, and immunological correlation of MCEMP1 and its potential role in gastric cancer","volume":"2022","author":"Huang","year":"2022","journal-title":"J Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib84","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2009-07-235341","article-title":"Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells","volume":"116","author":"Jiang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2025.105734_bib85","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1038\/s41598-019-41678-0","article-title":"Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma","volume":"9","author":"Punia","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2025.105734_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146760","article-title":"MCEMP1 is a potential therapeutic biomarker associated with immune infiltration in advanced gastric cancer microenvironment","volume":"840","author":"Wang","year":"2022","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib87","article-title":"Hemgn protects hematopoietic stem and progenitor cells against transplantation stress through negatively regulating IFN-\u03b3 signaling","volume":"9","author":"Zhao","year":"2022","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib88","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13045-021-01184-1","article-title":"The roles of GTPase-activating proteins in regulated cell death and tumor immunity","volume":"14","author":"He","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ebiom.2025.105734_bib89","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.2147\/OTT.S207560","article-title":"ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1\u03b1 signaling pathways","volume":"12","author":"Shen","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105734_bib90","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s13555-023-00977-1","article-title":"Matching-adjusted indirect comparison of the long-term efficacy of deucravacitinib versus adalimumab for moderate to severe plaque psoriasis","volume":"13","author":"Armstrong","year":"2023","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105734_bib91","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.42391","article-title":"Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: a phase II, randomized, double-blind, placebo-controlled trial","volume":"75","author":"Morand","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105734_bib92","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/art.42547","article-title":"Differences in JAK isoform selectivity among different types of JAK inhibitors evaluated for rheumatic diseases through in vitro profiling","volume":"75","author":"Virtanen","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ebiom.2025.105734_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1263926","article-title":"Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-\u03b2H1 \u03b2-cells against proinflammatory insults","volume":"14","author":"Dos Santos","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/db06-0493","article-title":"Altered natural killer cells in type 1 diabetic patients","volume":"56","author":"Rodacki","year":"2007","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib95","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1038\/s41467-023-42763-9","article-title":"Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection","volume":"14","author":"Lin","year":"2023","journal-title":"Nat Commun"},{"issue":"587","key":"10.1016\/j.ebiom.2025.105734_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5666","article-title":"Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression","volume":"13","author":"Xhonneux","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2025.105734_bib97","article-title":"Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset","author":"Golden","year":"2024","journal-title":"bioRxiv"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105734_bib98","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic cells as inducers of peripheral tolerance","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ebiom.2025.105734_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front Immunol"},{"issue":"27","key":"10.1016\/j.ebiom.2025.105734_bib100","doi-asserted-by":"crossref","first-page":"E2480","DOI":"10.1073\/pnas.1305394110","article-title":"Strength of PD-1 signaling differentially affects T-cell effector functions","volume":"110","author":"Wei","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105734_bib101","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"583","key":"10.1016\/j.ebiom.2025.105734_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib103","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-8587(13)70065-2","article-title":"Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial","volume":"1","author":"Gitelman","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105734_bib104","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Low-dose anti-thymocyte globulin (ATG) preserves \u03b2-cell function and improves HbA1c in new-onset type 1 diabetes","volume":"41","author":"Haller","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105734_bib105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc17-1387","article-title":"Islet interleukin-1\u03b2 immunoreactivity is an early feature of cystic fibrosis that may contribute to \u03b2-cell failure","volume":"41","author":"Hull","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib106","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182232","article-title":"PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance","volume":"218","author":"Tan","year":"2020","journal-title":"J Exp Med"},{"issue":"20","key":"10.1016\/j.ebiom.2025.105734_bib107","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105734_bib108","doi-asserted-by":"crossref","first-page":"bbad249","DOI":"10.1093\/bib\/bbad249","article-title":"RNA trafficking and subcellular localization\u2014a review of mechanisms, experimental and predictive methodologies","volume":"24","author":"Wang","year":"2023","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.ebiom.2025.105734_bib109","article-title":"Statistical analysis supports pervasive RNA subcellular localization and alternative 3\u2019 UTR regulation","author":"Bierman","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.ebiom.2025.105734_bib110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fmolb.2019.00161","article-title":"The role of RNA binding proteins for local mRNA translation: implications in neurological disorders","volume":"6","author":"Thelen","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"23","key":"10.1016\/j.ebiom.2025.105734_bib111","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105734_bib112","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","article-title":"A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring","volume":"13","author":"Samuel","year":"2023","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105734_bib113","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s41927-022-00287-7","article-title":"Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"6","author":"Sarabia","year":"2022","journal-title":"BMC Rheumatol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:39:08Z","timestamp":1778873948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":111,"alternative-id":["S2352396425001781"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105734","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.20.585925","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105734"}}